Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Published byJacques Bossé Modified over 5 years ago

Similar presentations

Presentation on theme: "Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J"— Presentation transcript:

1 Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer 
Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J. Speicher, MD, Brian C. Gulack, MD, Betty C. Tong, MD, Matthew G. Hartwig, MD, Christopher R. Kelsey, MD, Thomas A. D’Amico, MD, Mark F. Berry, MD, David H. Harpole, MD  The Annals of Thoracic Surgery  Volume 103, Issue 6, Pages (June 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Consolidated Standards of Reporting Trials (CONSORT) diagram showing schema of study subject selection (clinical T1–3 N1 M0 patients). (RT = radiation; SCLC = small cell lung cancer.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Overall survival of cT1–3 N1 M0 small cell lung cancer (SCLC) patients, stratified by surgery versus concurrent chemoradiation. (CI = confidence interval; RT = radiation.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Overall survival of cT1–3 N1 M0 small cell lung cancer (SCLC) patients, stratified by surgery versus concurrent chemoradiation: propensity score-matched analysis. (CI = confidence interval; RT = radiation.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 (A) Overall survival of cT1–3 N1 M0 small cell lung cancer (SCLC) patients who underwent wedge resection versus lobectomy. (B) Overall survival of cT1–3 N1 M0 SCLC patients who underwent wedge resection or lobectomy and did not have positive margins. (CI = confidence interval.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 Overall survival of cT1–3 N1 M0 small cell lung cancer (SCLC) patients with no comorbidities, stratified by surgery versus concurrent chemoradiation. (CI = confidence interval; RT = radiation.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer  Babatunde A. Yerokun, MD, Chi-Fu.

A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer  Babatunde A. Yerokun, MD, Chi-Fu.
Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma  Chi-Fu Jeffrey Yang, MD, Hanghang Wang, MD, PhD, Arvind.

Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma  Chi-Fu Jeffrey Yang, MD, Hanghang Wang, MD, PhD, Arvind.
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis  Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,

Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis  Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,
Trevor Williams, MD, MPH, Brian C

Trevor Williams, MD, MPH, Brian C
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer  Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer  Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery 

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery 
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,
Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Similar presentations

Ads by Google